Dabrafenib Mesylate and Japanese encephalitis virus vaccine SA14-14-2
Determining the interaction of Dabrafenib Mesylate and Japanese encephalitis virus vaccine SA14-14-2 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dabrafenib
Brand name: Tafinlar
Synonyms: Dabrafenib
Generic Name: japanese enceph vacc sa14-14-2, inactivated
Brand name: Ixiaro
Synonyms: Japanese encephalitis virus vaccine (SA14-14-2), Japanese Encephalitis Virus Vaccine (Inactivated)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dabrafenib Mesylate-Jardiance
- Dabrafenib Mesylate-Jasmiel
- Dabrafenib Mesylate-Jatenzo
- Dabrafenib Mesylate-Jay-Phyl
- Dabrafenib Mesylate-Jay-Phyl Syrup
- Dabrafenib Mesylate-Jencycla
- Japanese encephalitis virus vaccine SA14-14-2-Dacarbazine
- Japanese encephalitis virus vaccine SA14-14-2-Dacarbazine Intravenous, Injection
- Japanese encephalitis virus vaccine SA14-14-2-Daclatasvir
- Japanese encephalitis virus vaccine SA14-14-2-Daclatasvir Dihydrochloride
- Japanese encephalitis virus vaccine SA14-14-2-Daclizumab
- Japanese encephalitis virus vaccine SA14-14-2-Daclizumab Subcutaneous